Reagent Strip Glucose Monitoring Methods in Chronic Hemodialysis
- Candace J Wason, R.N., M.S.,
- Jacqueline Green, M.D.,
- Clara Miller, R.N. and
- David M Roxe, M.D.
- Section of Nephrology/Hypertension, Northwestern University Medical School and Department of Nursing, Northwestern Memorial Hospital Chicago, Illinois
- Address reprint requests to David M. Roxe, M.D., 251 East Chicago Avenue, Suite 1230—Allison Pavilion, Chicago, Illinois 60611.
Abstract
Reagent strip blood glucose testing methods have not been extensively validated in dialysis patients, a serious omission as thousands of diabetic patients are now entering dialysis. Severe anemia and uremia are potentially confounding variables that might impair those testing methods. Various methods were tested pre- and postdialysis, and compared with standard laboratory results. In general, strip methods (SM) underestimated laboratory results by approximately 15%. Extremes of blood urea nitrogen, hematocrit, or blood glucose levels did not affect this reliability. Such methods appear to be suitable for use in chronic hemodialysis patients.
- Copyright © 1985 by the American Diabetes Association











